Home > Insider Trading > Filing (0000885590-10-000014)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885590	Biovail Corp	BVF	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1477625	Paul John Douglas Squires	C/O Biovail Corporation 7150 Mississauga Road Mississauga A6 L5N 8M5		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, No Par Value	Acquisiton	2010-06-01	75,033	$10.83	104,721	No	4	M	Direct
Common Stock, No Par Value	Disposition	2010-06-01	75,033	$14.77	29,688	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, No Par Value	Stock Options (right to purchase)	Disposition	2010-06-01	75,033	$0.00	75,033	$10.83

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2008-05-06	2010-06-01	No	4	M	Direct

Footnotes

Stock Options were exercised and underlying Common Stock sold pursuant to a 10b5-1 Selling Plan adopted by the Reporting Person on June 29, 2009.
The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.61 to $14.92, inclusive. The reporting person undertakes to provide to Biovail Corporation, any security holder of Biovail Corporation, or the staff of the U.S. Securities and Exchange Commission, in each case upon request, full information regarding the number of shares sold at each separate price.